Bicycle Therapeutics plc 8-K Report: Stock Insights & Financial Updates

Here are the key insights extracted from the financial report section provided:

1. Entity Information:

• Company Name: Bicycle Therapeutics plc
• SEC Identifier (CIK): 0001761612
• Reporting Date: February 25, 2025

2. Stock Information:

• Common Stock: The report mentions the ordinary shares with a nominal value of £0.01 per share.
• American Depositary Shares (ADS): Each ADS represents one ordinary share, also with a nominal value of £0.01 per share.
• Stock Symbol: BCYC
• Stock Exchange: NASDAQ

3. Context Information:

• The report is structured using XBRL (eXtensible Business Reporting Language), which allows for efficient data extraction and analysis.
• The context identifiers indicate a focus on specific classes of stock, explicitly outlining common stock and American depositary shares.

4. Units and Measurements:

• The currency used is in U.S. Dollars (USD), with shares being the unit of measure.
• The report appears to reference both monetary values and share quantities, though specific numerical data is not included in the provided text.

5. Contact Information:

• Address: Blocks A & B, Portway Building, Granta Park, Great Abington, Cambridge, GB CB21 6GS
• Phone Number: +44 1223 261503

6. Filing Type: The filing type is indicated as an 8-K, which is a report used by publicly traded companies to announce major events that shareholders should know about.

Summary Insight:

This section of the financial report indicates that Bicycle Therapeutics plc is actively reporting its stock structure and relevant details of its ordinary shares and American Depositary Shares as of February 25, 2025. The use of XBRL for the report suggests a focus on transparency and accessibility of financial data for stakeholders.